The Effect of heparin solution sealing with different tube volumes on coagulation function in patients undergoing continuous renal replacement therapy
10.3760/cma.j.cn211501-20231127-01132
- VernacularTitle:连续性肾脏替代治疗中应用不同管腔容积的肝素溶液封管对患者凝血功能的影响
- Author:
Ying MA
1
;
Li FU
;
Yingying LI
;
Jin LIN
;
Jingfeng LIU
Author Information
1. 首都医科大学附属北京友谊医院重症医学科，北京 100050
- Keywords:
Continuous renal replacement therapy;
Non-cuffed catheter;
Heparin for tube sealing;
Catheter volume
- From:
Chinese Journal of Practical Nursing
2024;40(21):1628-1634
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the influence of various volumes of heparinized saline seal on coagulation function in patients undergoing Continuous Renal Replacement Therapy (CRRT) with non-tunneled hemodialysis catheters.Methods:A randomized controlled trial was conducted on patients requiring catheter sealing during CRRT in the Department of intensive care unit, Beijing Friendship Hospital Affiliated to Capital Medical University from March 2021 to December 2022. Patients were randomly assigned to either the experimental group or the control group, The control group used 100% catheter volume of heparinized solution, while the experimental group used 80% catheter volume of heparinized solution. Compare the activated partial thromboplastin time (APTT), prothrombin time (PT), prothrombin activity (PTA), fibrinogen (Fbg), hemoglobin, platelets, and poor prognosis events (mainly including clotting, bleeding, bleeding inclination) between two groups of patients.Results:A total of 121 patients were included in the study, with 59 in the experimental group and 62 in the control group. In the control group, there were 39 males and 23 females, with an average age of (66.6 ± 18.2) years, while in the experimental group, there were 29 males and 30 females, with an average age of (65.2 ± 17.5) years. After catheter sealing, APTT and PT in the experimental group were (41.2 ± 7.6) s and (14.0 ± 0.8) s, respectively, both lower than the corresponding values in the control group [(48.1 ± 14.7) s and (16.2 ± 4.0) s], with statistically significant differences ( t=4.32, 4.08, both P<0.05). In the experimental group, PTA, fibrinogen levels, and platelet were (77.9 ± 12.5) s, (90.3 ± 10.1) g/L, and (151.3 ± 89.4) × 10 9/L, respectively, higher than the corresponding values in the control group (65.3 ± 17.2) s, (85.2 ± 5.2) g/L, and (110.0 ± 21.6) ×10 9/L, with statistically significant differences ( t=-4.59, -5.03, -5.59, all P<0.05). After the closure of the tube, the bleeding incidence rate in the experimental group was 1.7% (1/59), which was significantly lower than that in the control group at 12.9% (8/62), with statistically significant differences ( χ2=0.12, P<0.05). Conclusions:Heparin solution sealing with 80% lumen capacity improves coagulation function, reduces bleeding risk, and does not increase the incidence of catheter blockage.
